Search Results - "Egerland, Ute"
-
1
Phosphodiesterase 10A inhibitor activity in preclinical models of the positive, cognitive, and negative symptoms of schizophrenia
Published in The Journal of pharmacology and experimental therapeutics (01-11-2009)“…Following several recent reports that suggest that dual cAMP and cGMP phosphodiesterase 10A (PDE10A) inhibitors may present a novel mechanism to treat positive…”
Get more information
Journal Article -
2
Effect of PDE10A inhibitors on MK-801-induced immobility in the forced swim test
Published in Psychopharmacologia (01-05-2012)“…Rational Negative symptoms of schizophrenia are insufficiently treated by current antipsychotics. However, research is limited by the lack of validated models…”
Get full text
Journal Article -
3
Highly Potent, Selective, and Orally Active Phosphodiesterase 10A Inhibitors
Published in Journal of medicinal chemistry (10-11-2011)“…The identification of highly potent and orally active phenylpyrazines for the inhibition of PDE10A is reported. The new analogues exhibit subnanomolar potency…”
Get full text
Journal Article -
4
Investigation of an 18F-labelled Imidazopyridotriazine for Molecular Imaging of Cyclic Nucleotide Phosphodiesterase 2A
Published in Molecules (Basel, Switzerland) (02-03-2018)“…Specific radioligands for in vivo visualization and quantification of cyclic nucleotide phosphodiesterase 2A (PDE2A) by positron emission tomography (PET) are…”
Get full text
Journal Article -
5
Radiosynthesis and biological evaluation of the new PDE10A radioligand [18F]AQ28A
Published in Journal of labelled compounds & radiopharmaceuticals (01-01-2017)“…Cyclic nucleotide phosphodiesterase 10A (PDE10A) regulates the level of the second messengers cAMP and cGMP in particular in brain regions assumed to be…”
Get full text
Journal Article -
6
Fluorine-Containing 6,7-Dialkoxybiaryl-Based Inhibitors for Phosphodiesterase 10 A: Synthesis and in vitro Evaluation of Inhibitory Potency, Selectivity, and Metabolism
Published in ChemMedChem (01-07-2014)“…Based on the potent phosphodiesterase 10 A (PDE10A) inhibitor PQ‐10, we synthesized 32 derivatives to determine relationships between their molecular structure…”
Get full text
Journal Article -
7
Synthesis, 18F-Radiolabelling and Biological Characterization of Novel Fluoroalkylated Triazine Derivatives for in Vivo Imaging of Phosphodiesterase 2A in Brain via Positron Emission Tomography
Published in Molecules (Basel, Switzerland) (26-05-2015)“…Phosphodiesterase 2A (PDE2A) is highly and specifically expressed in particular brain regions that are affected by neurological disorders and in certain…”
Get full text
Journal Article -
8
Anti-inflammatory potential of the selective phosphodiesterase 4 inhibitor N-(3,5-dichloro-pyrid-4-yl)-[1-(4-fluorobenzyl)-5-hydroxy-indole-3-yl]-glyoxylic acid amide (AWD 12-281), in human cell preparations
Published in The Journal of pharmacology and experimental therapeutics (01-02-2004)“…AWD 12-281 is a potent (IC(50) = 9.7 nM) and highly selective inhibitor of the phosphodiesterase 4 (PDE4) isoenzyme with low affinity to the high-affinity…”
Get more information
Journal Article -
9
Characterization in rats of the anxiolytic potential of ELB139 [1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydro-imidazol-2-on], a new agonist at the benzodiazepine binding site of the GABAA receptor
Published in The Journal of pharmacology and experimental therapeutics (01-08-2005)“…Benzodiazepines are among the most effective drugs for the treatment of anxiety disorders. However, their use is limited by undesired side effects, including…”
Get more information
Journal Article -
10
Discovery of triazines as potent, selective and orally active PDE4 inhibitors
Published in Bioorganic & medicinal chemistry letters (01-08-2013)“…Expanding on HTS hit 4 afforded a series of [1,3,5]triazine derivatives as novel PDE4 inhibitors. The SAR development and optimization process with the…”
Get full text
Journal Article -
11
Large-Scale Mining for Similar Protein Binding Pockets: With RAPMAD Retrieval on the Fly Becomes Real
Published in Journal of chemical information and modeling (26-01-2015)“…Determination of structural similarities between protein binding pockets is an important challenge in in silico drug design. It can help to understand…”
Get full text
Journal Article -
12
Development of highly potent phosphodiesterase 10A (PDE10A) inhibitors: Synthesis and in vitro evaluation of 1,8-dipyridinyl- and 1-pyridinyl-substituted imidazo[1,5-a]quinoxalines
Published in European journal of medicinal chemistry (01-01-2016)“…Herein we report the synthesis of fluorinated inhibitors of phosphodiesterase 10A (PDE10A) which can be used potentially as lead structure for the development…”
Get full text
Journal Article -
13
Synthesis and structure–activity relationship studies of dihydronaphthyridinediones as a novel structural class of potent and selective PDE7 inhibitors
Published in Bioorganic & medicinal chemistry letters (15-11-2011)“…The synthesis and SAR studies of a series of structurally novel inhibitors of PDE7 are discussed. The best compounds from the series display low nanomolar…”
Get full text
Journal Article -
14
Discovery of Imidazo[1,5-a]pyrido[3,2-e]pyrazines as a New Class of Phosphodiesterase 10A Inhibitiors
Published in Journal of medicinal chemistry (10-06-2010)“…Novel imidazo[1,5-a]pyrido[3,2-e]pyrazines have been synthesized and characterized as both potent and selective phosphodiesterase 10A (PDE10A) inhibitors. For…”
Get full text
Journal Article -
15
New GABA-modulating 1,2,4-oxadiazole derivatives and their anticonvulsant activity
Published in European journal of medicinal chemistry (01-06-2007)“…A series of 3- and 5-aryl-1,2,4-oxadiazole derivatives were prepared and tested for anticonvulsant activity in a variety of models. These 1,2,4-oxadiazoles…”
Get full text
Journal Article -
16
Novel triazines as potent and selective phosphodiesterase 10A inhibitors
Published in Bioorganic & medicinal chemistry letters (15-09-2012)“…Novel triazines are potent, selective and orally active Phosphodiestarase 10A inhibitors. The identification of highly potent and orally active triazines for…”
Get full text
Journal Article -
17
Fluorine-Containing 6,7-Dialkoxybiaryl-Based Inhibitors for Phosphodiesterase10A: Synthesis and in vitro Evaluation of Inhibitory Potency, Selectivity, and Metabolism
Published in ChemMedChem (01-07-2014)“…Based on the potent phosphodiesterase10A (PDE10A) inhibitor PQ-10, we synthesized 32 derivatives to determine relationships between their molecular structure…”
Get full text
Journal Article -
18
Investigation of an 18 F-labelled Imidazopyridotriazine for Molecular Imaging of Cyclic Nucleotide Phosphodiesterase 2A
Published in Molecules (Basel, Switzerland) (02-03-2018)“…Specific radioligands for in vivo visualization and quantification of cyclic nucleotide phosphodiesterase 2A (PDE2A) by positron emission tomography (PET) are…”
Get full text
Journal Article -
19
Synthesis, Pharmacology, and Structure−Activity Relationships of Novel Imidazolones and Pyrrolones as Modulators of GABAA Receptors
Published in Journal of medicinal chemistry (23-03-2006)“…New series of imidazolones and pyrrolones were synthesized. The compounds were tested regarding their anxiolytic properties due to modulation of the GABAA…”
Get full text
Journal Article -
20
Synthesis, Pharmacology, and Structure−Activity Relationships of Novel Imidazolones and Pyrrolones as Modulators of GABA A Receptors
Published in Journal of medicinal chemistry (23-03-2006)Get full text
Journal Article